Ruben A. Mesa

Also affiliated with Levine Cancer Institute, Wake Forest Baptist Comprehensive Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile

0.427Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-0592

Top 60%

0.253DataRank

Top 60%4 citations

Xiaoyi Wang, Rong Wang, Jonathan N. Hofmann, Linda M. Liao, Amer M. Zeidan +3 more

Papers

Driven by 29 papers — median percentile 37. Top paper: “Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study”.

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet(2020)10.1016/s0140-6736(20)31187-9

N/A

11.9DataRank · unranked

1804 citations

Toni K. Choueiri, Dimpy P. Shah, Yu Shyr, Samuel M. Rubinstein, Donna R. Rivera +95 more

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024

N/A

6.8DataRank · unranked

328 citations

Ali Raza Khaki, Trisha M. Wise‐Draper, Benjamin French, Conor Hennessy, Chih–Yuan Hsu +95 more

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial

Nature Medicine(2021)10.1038/s41591-021-01539-8

N/A

4.0DataRank · unranked

147 citations

Andreas Reiter, Deepti Radia, Michael W. Deininger, Tracy I. George, Jens Panse +19 more

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia

Blood(2022)10.1182/blood.2021012743

N/A

3.6DataRank · unranked

129 citations

Heidi E. Kosiorek, Josef T. Prchal, Alessandro Rambaldi, Dmitriy Berenzon, Abdulraheem Yacoub +38 more

Phase 2 study of ruxolitinib and decitabine in patients with myeloproliferative neoplasm in accelerated and blast phase

Blood Advances(2020)10.1182/bloodadvances.2020002119

N/A

2.2DataRank · unranked

73 citations

Raajit K. Rampal, Heidi Kosiorek, Rupali Bhave, Elizabeth O. Hexner, Eunice S. Wang +22 more

Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clipping

EMBO Reports(2023)10.15252/embr.202357032

N/A

0.875DataRank · unranked

21 citations

Pinpin Sui, Ying Guo, Shi Chen, Marie E. Maloof, Guo Ge +14 more

Pelabresib plus ruxolitinib for JAK inhibitor-naive myelofibrosis: a randomized phase 3 trial

Nature Medicine(2025)10.1038/s41591-025-03572-3

N/A

0.664DataRank · unranked

40 citations

Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds +23 more

Lifestyle factors and risk of myeloproliferative neoplasms in the NIH‐AARP diet and health study

International Journal of Cancer(2020)10.1002/ijc.32853

N/A

0.638DataRank · unranked

14 citations

Xiaoyi Wang, Rong Wang, Jonathan N. Hofmann, Linda M. Liao, Amer M. Zeidan +3 more

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities (Preprint)

(2020)10.2196/preprints.21697

N/A

0.482DataRank · unranked

4 citations

Zhaohui Su, Ruben A. Mesa, Gail E. Tomlinson, Jing Wang, Ramon S. Cancino

Insomnia as an Unmet Need in Patients With Chronic Hematological Cancer: Protocol for a Randomized Controlled Trial Evaluating a Consumer-Based Meditation App for Treatment of Sleep Disturbance

JMIR Research Protocols(2022)10.2196/39007

N/A

0.331DataRank · unranked

5 citations

Nishat Bhuiyan, Ryan Eckert, Linda Larkey, Megan E. Petrov, Michael Todd +2 more

Diet and Risk of Myeloproliferative Neoplasms in Older Individuals from the NIH-AARP Cohort

Cancer Epidemiology Biomarkers & Prevention(2020)10.1158/1055-9965.epi-20-0592

Top 60%

0.253DataRank

Top 60%4 citations

Xiaoyi Wang, Rong Wang, Jonathan N. Hofmann, Linda M. Liao, Amer M. Zeidan +3 more

An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.10565

Top 67%

0.175DataRank

Top 67%2 citations

Pankil Shah, Jeremy L. Warner, Gerald Batist, Christopher R. Friese, Elizabeth A. Griffiths +15 more

Longitudinal graphics of patient-reported physical function in patients treated for hematologic malignancies

BMC Medical Research Methodology(2025)10.1186/s12874-025-02617-y

N/A

0.165DataRank · unranked

2 citations

Vishal Bhatnagar, Brie N. Noble, Tingyu Chen, Mallorie H. Fiero, Ron Hoffman +11 more

Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution

Cell Reports(2021)10.1016/j.celrep.2020.108670

N/A

0DataRank · unranked

46 citations

Jane Isquith, Luisa Ladel, Adam Mark, Frida Holm, Cayla Mason +25 more

HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia

Nature Communications(2021)10.1038/s41467-021-22095-2

N/A

0DataRank · unranked

98 citations

Huacheng Luo, Yang Feng, Olga A. Guryanova, Jianfeng Xu, Shi Chen +16 more

Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer

Cancer Research(2020)10.1158/0008-5472.can-19-3183

N/A

0DataRank · unranked

62 citations

Chia-Nung Hung, Daniel T. DeArmond, Meizhen Chen, Chun-Lin Lin, Paweł A. Osmulski +19 more

Impact of imbalanced gender participation in online myeloproliferative neoplasm symptom surveys.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e19078

N/A

0DataRank · unranked

5 citations

Gina L. Mazza, Robyn M. Scherber, Holly L. Geyer, Krisstina Gowin, Jeanne Palmer +6 more

Fedratinib in myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019000954

N/A

0DataRank · unranked

89 citations

John Hood, Claire Harrison, Ruben A. Mesa, Ann Mullally

A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0276

N/A

0DataRank · unranked

34 citations

Anna Ritá Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall +29 more

Survival following allogeneic transplant in patients with myelofibrosis

Blood Advances(2020)10.1182/bloodadvances.2019001084

N/A

0DataRank · unranked

97 citations

Karen K. Ballen, Kwang Woo Ahn, Zhen‐Huan Hu, Haris Ali, Murat O. Arcasoy +63 more

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial

Haematologica(2023)10.3324/haematol.2022.282411

N/A

0DataRank · unranked

17 citations

Lynda Foltz, Vikas Gupta, Robert P. Hasserjian, Taghi Manshouri, John Mascarenhas +15 more

Targeting lysine demethylase 6B ameliorates ASXL1 truncation–mediated myeloid malignancies in preclinical models

Journal of Clinical Investigation(2023)10.1172/jci163964

N/A

0DataRank · unranked

10 citations

Peng Zhang, Pinpin Sui, Shi Chen, Hui Yang, Ying Guo +13 more

Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms

Cancer(2023)10.1002/cncr.34800

N/A

0DataRank · unranked

8 citations

Heidi Kosiorek, Amylou C. Dueck, Jeanne Palmer, Lisa Sproat, James M. Bogenberger +6 more

Proposals for revised International Working Group–European LeukemiaNet criteria for anemia response in myelofibrosis

Blood(2024)10.1182/blood.2024025802

N/A

0DataRank · unranked

25 citations

Giovanni Barosi, Francesco Passamonti, Juan Carlos Hernández‐Boluda, Prithviraj Bose, Konstanze Döhner +33 more

Improving Collection and Analysis of Overall Survival Data

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0919

N/A

0DataRank · unranked

17 citations

Nicole Gormley, Ruixiao Lu, Anup Amatya, George D. Demetri, Keith T. Flaherty +12 more

Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature

British Journal of Haematology(2024)10.1111/bjh.19557

N/A

0DataRank · unranked

12 citations

Lucia Masárová, Ruben A. Mesa, Claire Harrison, Jean‐Jacques Kiladjian, Naveen Pemmaraju +1 more

Impact of gender representativeness in online symptom survey and clinical trial participation among patients with myeloproliferative neoplasms

Leukemia & lymphoma/Leukemia and lymphoma(2024)10.1080/10428194.2024.2356058

N/A

0DataRank · unranked

3 citations

Amylou C. Dueck, Heidi Kosiorek, Carolyn Mead‐Harvey, Eric A. Meek, Lauren J. Rogak +9 more

The Impact of COVID-19 on Cancer Screening: Challenges and Opportunities

JMIR Cancer(2020)10.2196/21697

N/A

0DataRank · unranked

161 citations

Zhaohui Su, Ruben A. Mesa, Gail E. Tomlinson, Jing Wang, Ramon S. Cancino

Pharmacological Validation Of Potentiating Targets From SAHA RNA-Interference Modifier Screens In Acute Myeloid Leukemia

Blood(2013)10.1182/blood.v122.21.3832.3832

N/A

0DataRank · unranked

0 citations

James Rudd, Donald Chow, Michelle Kassner, Veena Fauble, Ruben A. Mesa +4 more

Ruben A. Mesa

Indexed papers

Top data-sharing exemplar

Papers